Literature DB >> 6105206

Phencyclidine-like discriminative effects of opioids in the rat.

S G Holtzman.   

Abstract

Possible commonalities in the discriminative stimulus properties of phencyclidine (PCP) and opioids were investigated in rats trained to discriminate between i.p. injections of saline and 2.0 mg/kg of PCP in a two-choice discrete-trial avoidance paradigm. Behavior was considered to be under stimulus control when a rat reliably completed at least 18 trials of a 20-trial session on the appropriate choice lever after receiving PCP or saline. Tests of stimulus generalization were performed over an 8- to 32-fold range of doses with ketamine, a PCP analog, and eight opioids. Dose- and time-dependent stimulus control of behavior comparable to that produced by 2.0 mg/kg of PCP (defined by the number of trials completed on the PCP-appropriate choice lever) were produced by ketamine and the opioids cyclazocine, SKF 10,047 and dextrorphan. These drugs also produced orderly increases in responses during the interval between trials suggestive of a relationship between this effect and PCP-like stimulus control. In contrast, after ethylketocyclazocine, ketocyclazocine, pentazocine and dextromethorphan trials were completed primarily on the saline-appropriate lever and responding between trials produced did not change. Neither the PCP-like stimulus control of behavior nor the increased responding between trials produced by cyclazocine were prevented by pretreatment with naltrexone (1.0 mg/kg). These results provide further evidence that PCP and certain opioids share a common component of action that is probably mediated by neuronal substrates not usually associated with the activity of opioids.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6105206

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  41 in total

Review 1.  Innovations in pharmacotherapy for stress urinary incontinence.

Authors:  Tracy W Cannon; Naoki Yoshimura; Michael B Chancellor
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2003-11-20

2.  Potentiation of disruptive effects of dextromethorphan by naloxone on fixed-interval performance in rats.

Authors:  T Taşkin
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

3.  Is the discriminative stimulus produced by phencyclidine due to an interaction with N-methyl-D-aspartate receptors?

Authors:  A Jackson; D J Sanger
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

4.  Effects of single or multiple choice trials per session on drug discrimination performance.

Authors:  A Tomie; L Peoples; G C Wagner
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

5.  Inhibition of (+)[3H]SKF 10,047 binding to rat brain membranes by FAB fragments from a monoclonal antibody directed against the opioid receptor.

Authors:  C B Tyler; J M Bidlack
Journal:  Neurochem Res       Date:  1988-08       Impact factor: 3.996

6.  Discriminative stimulus effects of spiradoline, a kappa-opioid agonist.

Authors:  S G Holtzman; L Cook; G F Steinfels
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

7.  Differential binding properties of [3H]dextrorphan and [3H]MK-801 in heterologously expressed NMDA receptors.

Authors:  K T LePage; J E Ishmael; C M Low; S F Traynelis; T F Murray
Journal:  Neuropharmacology       Date:  2005-04-01       Impact factor: 5.250

Review 8.  Neuropsychopharmacological understanding for therapeutic application of morphinans.

Authors:  Eun-Joo Shin; Jau-Shyong Hong; Hyoung-Chun Kim
Journal:  Arch Pharm Res       Date:  2010-10-30       Impact factor: 4.946

9.  Effects of phencyclidine, haloperidol, and naloxone on fixed-interval performance in rats.

Authors:  G C Wagner; D B Masters; A Tomie
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

10.  Phencyclidine-induced locomotor activity in the rat is blocked by 6-hydroxydopamine lesion of the nucleus accumbens: comparisons to other psychomotor stimulants.

Authors:  E D French; G Vantini
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.